Hypoproteinemia: Clinical Trials

2 trials for Hypoproteinemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Not yet recruiting 1
Phase 21Completed 1

Follow Hypoproteinemia: new trials by email Literature Review of Hypoproteinemia trials Research Report on Hypoproteinemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Clinical Study on the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Characteristics of GLR1075 Injection in Healthy Trial Participants and Cirrhotic Trial Participants With Ascites and Hypoalbuminemia
placebo GLR1075 Vehicle, Human Serum Albumin(HSA), GLR1075 Injection - Hypoalbuminemia in Cirrhotic Ascites
Phase 1Not yet recruitingGan & Lee Pharmaceuticals.1062026-10-072026-10-01
Causes and Prevention of Thromboembolic Disease in Nephrotic Syndrome
Dalteparin, Apixaban - Nephrotic Syndrome, Thromboembolic Disease
Phase 1 / Phase 2CompletedUniversity of Aarhus572021-03-252025-04-11

Narrower conditions

Hypoalbuminemia (2)  ·  Glomerulonephritis (1)  ·  Glomerulonephritis, Membranous (1)  ·  Nephrotic Syndrome (1)  ·  Proteinuria (1)  ·  Thromboembolism (1)

Broader conditions

Blood Protein Disorders (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Autoimmune Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Immune System Diseases (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nephritis (1)  ·  Nephrosis (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Dalteparin (1)  ·  Serum Albumin, Human (1)  ·  apixaban (1)

Sponsors

Gan & Lee Pharmaceuticals. (1)  ·  University of Aarhus (1)

Countries

China (1)  ·  Denmark (1)

Top investigators

Sarah Kelddal, MD (1)

Results publications

PMID 40478760, PMID 41333097